A high-throughput, multiplex cell death assay using an RNAi screening approach.

Cold Spring Harb Protoc 2014 Jun 2;2014(6):663-76. Epub 2014 Jun 2.

Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia Department of Pathology, The University of Melbourne, Parkville, Victoria 3052, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3052, Australia.

This protocol outlines a high-throughput, multiplex cell death assay and its use in conjunction with a genome-scale siRNA screen to identify genes that cooperate with a drug to induce apoptosis. The assay, ApoLive-Glo (Promega), measures viability of drug-treated, reverse-transfected cells via the fluorescent CellTiter-Fluor reagent, which includes a substrate that is cleaved by a live cell protease. ApoLive-Glo also quantitates cell death by the amount of cleaved caspases 3 and 7 using a luminescent Caspase-Glo 3/7 caspase activation assay. The advantage of the multiplex assay is that it distinguishes rapid cell death from the slower activation of caspase activity, permitting measurement of different stages of cell death in the same sample at a single time point. In parallel, a high-content imaging protocol involving 4',6-diamidino-2-phenylindole-stained nuclei is used as a cost-effective way to quantitate viability of vehicle-treated control cells. Automation and robotic liquid handling are built into the protocol to increase speed of workflow and improve reproducibility. A screen using these assays will identify gene targets that are essential for viability irrespective of drug treatment and gene targets that cause a synergistic enhancement of cell death in the presence of drug. Candidate target activity can then be validated by conventional flow cytometry-based assays.

Download full-text PDF

Source
http://dx.doi.org/10.1101/pdb.prot080267DOI Listing
June 2014
6 Reads

Publication Analysis

Top Keywords

cell death
24
gene targets
8
multiplex cell
8
death assay
8
high-throughput multiplex
8
cell
7
death
6
assay
5
parallel high-content
4
point parallel
4
high-content imaging
4
time point
4
death sample
4
imaging protocol
4
sample single
4
single time
4
nuclei cost-effective
4
quantitate viability
4
viability vehicle-treated
4
vehicle-treated control
4

Similar Publications